HISTOGUARD
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

HISTOGUARD Trademark

Serial Number: 79270198 • Registration: 6150038

HISTOGUARD is a trademark filed by Histogenex, naamloze vennootschap on July 29, 2019. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Histogenex, naamloze vennootschap

Sint Bavostraat 78

Entity Type: 32

Trademark Details

Filing Date

July 29, 2019

Registration Date

September 15, 2020

Published for Opposition

June 30, 2020

Goods & Services

Medical services; medical analysis services for the diagnosis of cancer, oncological, neurological and inflammatory diseases; medical testing for diagnosis and treatment purposes; advisory services relating to physical health care; medical analysis services for the diagnosis of cancer and other diseases; RNA and DNA screening for cancer diagnosis and prognosis; pathology services, namely, medical screening for cancer diagnosis and prognosis

Scientific and technological services, research, consultancy, development and design, namely, clinical research in the field of cancer, oncology, neurological, inflammatory diseases, cancerous diseases, immunotherapy, histopathology, digital pathology, next generation immunohistochemistry, dna/mrna, fluorescence and silver in-situ hybridization, molecular pathology and all analytical methods covering morphological evaluation of specimens; medical laboratory services; clinical tests and clinical research, namely, conducting clinical trial services for others and providing advisory services related to the conduction of clinical trials; scientific laboratory services; analytical scientific laboratory services; scientific research for medical purposes in the area of cancerous diseases; providing information in the field of conducting clinical trials for others in the nature of scientific reports and reports related to scientific research and clinical tests; scientific and medical research; providing medical and scientific research information in the field of clinical trials; genetic testing for scientific research purposes; design and development of computer hardware and software

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 26, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 7, 2025 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 15, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 23, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 31, 2020 FICS
FINAL DISPOSITION PROCESSED
Dec 30, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 15, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 15, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 30, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 30, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Jun 27, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 10, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 10, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 10, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 28, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
May 28, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 28, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
May 28, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 28, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 21, 2020 TROA
REFUSAL PROCESSED BY IB
Dec 20, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 23, 2019 RFCS
REFUSAL PROCESSED BY MPU
Nov 22, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 2, 2019 RFCR
NON-FINAL ACTION WRITTEN
Nov 1, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 1, 2019 MAFR
ASSIGNED TO EXAMINER
Oct 28, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 28, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 24, 2019 REPR